{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Oscar Health, Inc.
Oscar Health Hits Day High with 8.68% Surge Amid Market Decline
Oscar Health, Inc. has seen a significant rise in its stock today, reaching an intraday high and contrasting with a decline in the S&P 500. Year-to-date, the company has outperformed the index, though it has faced challenges over the past year. Its market capitalization stands at USD 5,250 million.
Oscar Health, Inc. Hits New 52-Week High at $23.74
Oscar Health, Inc. achieved a new 52-week high of USD 23.74 on October 7, 2025, reflecting a year-over-year performance of 9.56%. With a market capitalization of USD 5,250 million, the company has a P/E ratio of 32.00 and a price-to-book ratio of 4.53, indicating its valuation dynamics.
Oscar Health, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Market Performance
Oscar Health, Inc. has recently revised its evaluation, reflecting strong market dynamics. The stock has shown impressive performance, with a year-to-date return of 66% and a three-year return of 369.68%. Technical indicators suggest a generally positive outlook, highlighting the company's resilience in the competitive healthcare services sector.
Is Oscar Health, Inc. technically bullish or bearish?
As of October 3, 2025, Oscar Health, Inc. is in a bullish trend with strong indicators, despite some caution from the KST and OBV, and has outperformed the S&P 500 with a year-to-date return of 66.0% compared to 14.18%.
Oscar Health Hits Day High with 12.34% Surge in Strong Intraday Performance
Oscar Health, Inc. has seen a notable rise in its stock performance, reaching an intraday high and demonstrating significant market activity. While the company has outperformed the S&P 500 in recent weeks and year-to-date, it has faced challenges over the past year, reflecting its financial volatility.
Is Oscar Health, Inc. technically bullish or bearish?
As of October 3, 2025, Oscar Health, Inc. shows a bullish technical trend with strong momentum indicators, despite mixed signals from KST and OBV, and has significantly outperformed the S&P 500 year-to-date and over three years.
Is Oscar Health, Inc. technically bullish or bearish?
As of October 3, 2025, Oscar Health, Inc. is in a bullish trend with strong indicators like a bullish MACD and Bollinger Bands, despite some caution from the KST and OBV, and has outperformed the S&P 500 with a year-to-date return of 61.16% compared to 14.18%.
Is Oscar Health, Inc. technically bullish or bearish?
As of August 1, 2025, Oscar Health, Inc. shows a mildly bullish technical trend, supported by bullish MACD and moving averages, despite mixed signals from KST and OBV, while outperforming the S&P 500 year-to-date but underperforming over the past year.
Is Oscar Health, Inc. overvalued or undervalued?
As of August 6, 2025, Oscar Health, Inc. is considered overvalued with a risky valuation grade, reflected by its high P/E ratio of 32 and EV to EBITDA ratio of 40.04, despite impressive three-year growth, as it has underperformed the S&P 500 over the past year.
Oscar Health Stock Soars 7.54%, Hits Intraday High of $19.17
Oscar Health, Inc. saw a notable increase in its stock performance on September 18, 2025, reaching an intraday high of USD 19.17. The company has demonstrated strong short-term gains, significantly outperforming the S&P 500, while facing challenges over the past year. Its market capitalization is USD 5,250 million.
Is Oscar Health, Inc. overvalued or undervalued?
As of October 10, 2023, Oscar Health, Inc. is considered overvalued due to its high price-to-earnings (45.2), price-to-sales (2.8), and price-to-book (7.1) ratios compared to industry peers, indicating that investors are paying a significant premium relative to its financial metrics.
Is Oscar Health, Inc. technically bullish or bearish?
As of October 1, 2023, there is insufficient technical data for Oscar Health, Inc. to determine a bullish or bearish outlook.
What does Oscar Health, Inc. do?
Oscar Health, Inc. is a small-cap company in the Healthcare Services industry, with a market cap of approximately $4.1 billion and a net profit of $276 million as of March 2025. Key metrics include a P/E ratio of 32.00 and a return on equity of 9.31%.
How big is Oscar Health, Inc.?
As of Jun 18, Oscar Health, Inc. has a market capitalization of $4.11 billion and reported net sales of $0.00 million with a net profit of $124.15 million over the latest four quarters. The company's shareholder's funds were $1.01 billion, and total assets amounted to $4.55 billion as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
